Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01535157
Title Fenretinide/LXS Oral Powder Plus Ketoconazole in Recurrent Ovarian Cancer
Recruitment Terminated
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors South Plains Oncology Consortium
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104 United States Details
The University of Texas Southwestern Medical Center Dallas Texas 75390 United States Details
Joe Arrington Cancer Research and Treatment Center Lubbock Texas 79416 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field